High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients

doi:10.3748/wjg.v16.i36.4611

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4115)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

384

HTML

3191

Figures (1-2)

287

Tables (1-2)

253

Sum=4115

Sep 28, 2010 (publication date) through Feb 24, 2025

Times Cited of This Article

Times Cited (33)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 28, 2010; 16(36): 4611-4615
Published online Sep 28, 2010. doi: 10.3748/wjg.v16.i36.4611

Full Size Figure Download Figure

Figure 2 Overall survival rate of hepatocellular carcinoma patients estimated according to the epidermal growth factor-like repeats and discoidin I-like domains 3 expression level in hepatocellular carcinoma tissue samples (Kaplan-Meier method) with immunohistochemical staining.

Citation: Sun JC, Liang XT, Pan K, Wang H, Zhao JJ, Li JJ, Ma HQ, Chen YB, Xia JC. High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients. World J Gastroenterol 2010; 16(36): 4611-4615
URL: https://www.wjgnet.com/1007-9327/full/v16/i36/4611.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i36.4611